Misplaced Pages

Mycetoma

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chronic skin infection of bacteria or fungi Medical condition
Mycetoma
SpecialtyInfectious diseases
SymptomsTriad: painless firm skin lump, multiple weeping sinuses, grainy discharge
Usual onsetSlowly progressive
Types
Diagnostic methodUltrasound, fine needle aspiration

Mycetoma is a chronic infection in the skin caused by either bacteria (actinomycetoma) or fungi (eumycetoma), typically resulting in a triad of painless firm skin lumps, the formation of weeping sinuses, and a discharge that contains grains. 80% occur in feet.

Most eumycetoma is caused by M. mycetomatis, whereas most actinomycetoma is caused by N. brasiliensis, S. somaliensis, A. madurae and Actinomadura pelletieri. People who develop mycetoma likely have a weakened immune system. It can take between 3 months to 50 years from time of infection to first seeking healthcare advice.

Diagnosis requires ultrasound and fine needle aspiration.

While most cases of mycetoma occur in Sudan, Venezuela, Mexico, and India, its true prevalence and incidence are not well-known. It appears most frequently in people living in rural areas, particularly in farmers and shepherds, who are often men between 20 and 40 years earning the primary incomes for their families. It has been reported since 1840. Noteworthy, the diagnosis of mycetoma in non-endemic or low endemic areas as Europe and North Africa is challenging. Physicians in these areas are usually unfamiliar with the disease-specific manifestations and need to exercise extra vigilance regarding those patients who are at high risk of contracting mycetoma infections. Recent evidence suggests that Egypt, which borders sub-Saharan Africa, is a low-endemic country. Additionally, recent evidence suggests that Pakistan, which borders India, is a moderate-endemic country. Unlike bacterial acute hematogenous osteomyelitis and septic arthritis, misdiagnosed or delayed diagnosis of mycetoma osteomyelitis can result in amputation or radical resection. The disease is listed by the World Health Organization (WHO) as a neglected tropical disease.

Risk

Frequent exposure to penetrating wounds by thorns or splinters is a risk factor. This risk can be reduced by disinfecting wounds and wearing shoes.

Pathogenesis

Mycetoma is caused by common saprotrophs found in the soil and on thorny shrubs in semi-desert climates. Some common causative agents are:

Infection is caused as a result of localized skin trauma, such as stepping on a needle or wood splinter, or through a pre-existing wound.

The first visible symptom of mycetoma is a typically painless swelling beneath the skin; over several years, this will grow to a nodule (lump). Affected people will experience massive swelling and hardening of the area, in addition to skin rupture and the formation of sinus tracts that discharge pus and grains filled with organisms. In many instances, the underlying bone is affected. Some people with mycetoma will not experience pain or discomfort, while others will report itching and/or pain.

Diagnosis

There are currently no rapid diagnostic tools for mycetoma. Mycetoma is diagnosed through microscopic examination of the grains in the nodule and by analysis of cultures. Since the bacterial form and the fungal form of mycetoma infection of the foot share similar clinical and radiological features, diagnosis can be a challenge. Magnetic resonance imaging is a very valuable diagnostic tool. However, its results should be closely correlated with the clinical, laboratory and pathological findings.

Treatment

Currently, itraconazole is used for the treatment of mycetoma. Recent research found fosravuconazole can also be used to treat the disease.

While treatment will vary depending on the cause of the condition, it may include antibiotics or antifungal medication. Actinomycetoma, the bacterial form, can be cured with antibiotics. Eumycetoma, the fungal form, is treated with antifungals. Surgery in the form of bone resection may be necessary in late presenting cases or to enhance the effects of medical treatment. In the more extensive cases amputation is another surgical treatment option. For both forms, extended treatment is necessary.

Epidemiology

Human mycetoma in India in 2013

Mycetoma is endemic in some regions of the tropics and subtropics. India, sub-Saharan Africa as Sudan, and Mexico are most affected. Pakistan is probably a moderate-endemic country. Sporadic cases have been reported across some North African countries. Egypt is probably a low-endemic country.

Other animals

In cats, mycetoma can be treated with complete surgical removal. Antifungal drugs are rarely effective.

References

  1. ^ Zijlstra, Eduard E.; Sande, Wendy W. J. van de; Welsh, Oliverio; Mahgoub, El Sheikh; Goodfellow, Michael; Fahal, Ahmed H. (1 January 2016). "Mycetoma: a unique neglected tropical disease". The Lancet Infectious Diseases. 16 (1): 100–112. doi:10.1016/S1473-3099(15)00359-X. ISSN 1473-3099. PMID 26738840.
  2. ^ Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH (October 2014). "Mycetoma medical therapy". PLOS Neglected Tropical Diseases. 8 (10): e3218. doi:10.1371/journal.pntd.0003218. PMC 4199551. PMID 25330342.
  3. ^ van de Sande WW, Maghoub El S, Fahal AH, Goodfellow M, Welsh O, Zijlstra E (March 2014). "The mycetoma knowledge gap: identification of research priorities". PLOS Neglected Tropical Diseases. 8 (3): e2667. doi:10.1371/journal.pntd.0002667. PMC 3967943. PMID 24675533.
  4. ^ Sande, Wendy W. J. van de (7 November 2013). "Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis". PLOS Neglected Tropical Diseases. 7 (11): e2550. doi:10.1371/journal.pntd.0002550. ISSN 1935-2735. PMC 3820768. PMID 24244780.
  5. ^ Ahmed, SA; El-Sobky, TA; de Hoog, S; Zaki, SM; Taha, M (9 September 2022). "A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map". Transactions of the Royal Society of Tropical Medicine and Hygiene. 117 (1): 1–11. doi:10.1093/trstmh/trac085. PMC 9808524. PMID 36084235.
  6. Buonfrate, D; Gobbi, F; Angheben, A; Marocco, S; Farina, C; Van Den Ende, J; Bisoffi, Z (2014). "Autochthonous cases of mycetoma in Europe: report of two cases and review of literature". PLOS ONE. 9 (6): e100590. Bibcode:2014PLoSO...9j0590B. doi:10.1371/journal.pone.0100590. PMC 4070928. PMID 24963778.
  7. Barış, Ayşe; Öncül, Ahsen; Öztürk, Kahraman; Barış, Alican; Aykut, Serkan; Aktaş, Elif (19 April 2021). "Mikolojik Tanının Önemi: 20 Yıl İhmal Edilen Bir Scedosporium apiospermum Kompleks Miçetoma Olgusu". Mikrobiyoloji Bulteni. 55 (2): 256–264. doi:10.5578/mb.20219911. PMID 33882656. S2CID 241887330.
  8. ^ Zeeshan, Mohammad; Fatima, Saira; Farooqi, Joveria; Jabeen, Kauser; Ahmed, Arsalan; Haq, Afreen; Arif, Muhammad Omer; Zafar, Afia (29 July 2022). "Reporting of mycetoma cases from skin and soft tissue biopsies over a period of ten years: A single center report and literature review from Pakistan". PLOS Neglected Tropical Diseases. 16 (7): e0010607. doi:10.1371/journal.pntd.0010607. PMC 9365187. PMID 35905141.
  9. ^ "Mycetoma". Genetic and Rare Diseases Information Center (GARD). National Institutes of Health. Retrieved 2018-04-17.
  10. ^ RESERVED, INSERM US14 -- ALL RIGHTS. "Orphanet: Mycetoma". www.orpha.net. Retrieved 2018-04-17.{{cite web}}: CS1 maint: numeric names: authors list (link)
  11. Verma, P.; Jha, A. (March 2019). "Mycetoma: reviewing a neglected disease". Clinical and Experimental Dermatology. 44 (2): 123–129. doi:10.1111/ced.13642. PMID 29808607. S2CID 44123860.
  12. ^ El-Sobky, TA; Haleem, JF; Samir, S (2015). "Eumycetoma Osteomyelitis of the Calcaneus in a Child: A Radiologic-Pathologic Correlation following Total Calcanectomy". Case Reports in Pathology. 2015: 129020. doi:10.1155/2015/129020. PMC 4592886. PMID 26483983.
  13. ^ Karrakchou, B; Boubnane, I; Senouci, K; Hassam, B (10 January 2020). "Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region". BMC Dermatology. 20 (1): 1. doi:10.1186/s12895-019-0097-1. PMC 6953183. PMID 31918687.
  14. Johnson, Sarah (23 November 2023). "Cheap over-the-counter nail drug found to work on crippling flesh-eating disease". The Guardian. Retrieved 24 November 2023.
  15. Efared, Boubacar; Tahiri, Layla; Boubacar, Marou Soumana; Atsam-Ebang, Gabrielle; Hammas, Nawal; Hinde, El Fatemi; Chbani, Laila (December 2017). "Mycetoma in a non-endemic area: a diagnostic challenge". BMC Clinical Pathology. 17 (1): 1. doi:10.1186/s12907-017-0040-5. ISSN 1472-6890. PMC 5288886. PMID 28167862.
  16. Oladele, RO; Ly, F; Sow, D; Akinkugbe, AO; Ocansey, BK; Fahal, AH; van de Sande, WWJ (14 April 2021). "Mycetoma in West Africa". Transactions of the Royal Society of Tropical Medicine and Hygiene. 115 (4): 328–336. doi:10.1093/trstmh/trab032. PMID 33728466.
  17. Elgallali, N; El Euch, D; Cheikhrouhou, R; Belhadj, S; Chelly, I; Chaker, E; Ben Osman, A (June 2010). "". Médecine Tropicale. 70 (3): 269–73. PMID 20734597.
  18. Eldredge, Debra M.; Carlson, Delbert G.; Carlson, Liisa D.; Giffin, James M. (2008). Cat Owner's Home Veterinary Handbook. Howell Book House. p. 160.

External links

  • DermNet NZ: an online resource about skin diseases from the New Zealand Dermatological Society Incorporated.
  • Orphanet: a reference portal from Europe that provides information on rare diseases and orphan drugs.
  • ClinicalTrials.gov: a list of clinical trials related to mycetoma.
Categories: